The present results suggest a biphasic regulation or “immune-editing”, whereby TRAF3 is Lys63 polyubiquitinated early after virus infection to bridge protein-protein interactions between MAVS and TBK1/IKKε. Here, TRAF3 is linked to viral infectious disease.